The main endpoints were the comparative diagnostic values of LF-Fib in NAFLD pts with or without T2DM for cirrhosis (F4) and severe fibrosis (F3F4) using liver stiffness measurements (LSM M/XL), Hepascore (HS), FibroSure (FS), FIB4, APRI and Forns, and liver biopsy (LB) as reference, in a prospectively collected cohort from 2003 in the University Hospital Center (CHU) of Bordeaux, France (NCT01241227).
Find out more.